Psoriasis (41)
Psoriasis: An Opportunity to Identify Cardiovascular Risk
Psoriasis is highly prevalent and is associated with skin-associated complaints as well as arthritis, depression and a lower quality of life. Recently, it has been demonstrated that not only do patients with psoriasis have an increased prevalence of cardiovascular risk factors, but an increased risk of myocardial infarction, and for those with
Assessment of Patients With Recalcitrant Psoriasis in a Randomized, Observer-Blind, Vehicle-Controlled Trial Using Indigo.
CONCLUSION: Topical indigo naturalis (the Chinese herb Qing Dai) ointment was a novel, safe, and effective therapy for plaque-type psoriasis.
Psoriasis is a systemic disease
Psoriasis has been diagnosed as a disorder for thousands of years in both the east and western worlds. Chinese medicine has always viewed psoriasis as systemic disease that responds very well to the use of internally administered medicinals. Modern western medicine has struggled with it's understanding of psoriasis, in both treatment and diagnosis, and it has only been in the recent past that psoriasis is being viewed as a systemic problem.
The Chinese herb Jiang Huang, aka Tumeric, found to be twice as effective in relieving psoriasis than western drug calcipotriol.
Sometimes it seems that the simpliest and common things are the best for us. Tumeric (Curcumin Longae) the common kitchen spice and Chinese herbal remedy (Jiang Huang), was shown to be very effective at reducing the thick plaques of psoriasis. In fact the researchers who did the study found that Tumeric was twice as effective as the western drug calcipotriol, also known as Dovonex.
Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis
BACKGROUND: Phosphorylase kinase (PhK), also known as adenosine triphosphate (ATP)-phosphorylase b phosphotransferase, integrates multiple calcium/calmodulin-dependent signalling pathways, including those involved in cell migration and cell proliferation, while coupling these pathways to glycogenolysis and ATP-dependent phosphorylation,



